<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-61352</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women</dc:title>
<dc:description xml:lang="en">Introduction: To estimate the seroprevalence of infection by Trypanosoma cruzi and human T lymphotropic virus (HTLV) in pregnant Latin American women. MethodsSerological survey carried out in pregnant Latin American women attending the antenatal care clinic of a Spanish hospital from January 2006 to June 2007. Results: Of the 229 women enrolled, 4 had antibodies against T. cruzi (1.75%; 95% confidence interval [95% CI], 0.68¿4.4); 2 of these women came from Bolivia (13.33%; 95% CI, 3.73¿37.88) and the other 2 from Paraguay (11.76%; 95% CI, 3.29¿34.33). None of the women had anti-HTLV-1 antibodies (95% CI, 0¿1.6), and 2 had HTLV-2 antibodies (0.87; 95% CI, 0.24¿3.12). Conclusions: A notable percentage of pregnant immigrant women from Latin American had T. cruzi infection. The seroprevalence of HTLV infection is low (AU)</dc:description>
<dc:creator>Milla, Alfredo</dc:creator>
<dc:creator>Gutiérraz, Félix</dc:creator>
<dc:creator>Sánchez, Victoria</dc:creator>
<dc:creator>Toro, Carlos</dc:creator>
<dc:creator>Vergés, Mireia</dc:creator>
<dc:creator>Ramos, José Manuel</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: estimar la seroprevalencia de infección por Trypanosoma cruzi y por el virus linfotrópico humano (HTLV) en mujeres gestantes latinoamericanas. Métodos: estudio serológico en mujeres gestantes latinoamericanas que acudieron a la consulta de fisiopatología fetal de un hospital español desde enero de 2006 hasta junio de 2007. Resultados: de las 229 gestantes estudiadas, 4 fueron positivas frente a T. cruzi (1,75%; intervalo de confianza [IC] del 95%, 0,68¿4,4): 2 de Bolivia (13,33%; IC del 95%, 3,73¿37,88) y 2 de Paraguay (11,76%; IC del 95%, 3,29¿34,33). Ninguna mujer presentó anticuerpos frente al HTLV-1 (IC del 95%, 0¿1,6) y 2 presentaron anticuerpos frente al HTLV-2 (0,87%; IC del 95%, 0,24¿3,12). Conclusiones: una proporción apreciable de las gestantes inmigrantes latinoamericanas presenta anticuerpos frente a T. cruzi. La seroprevalencia frente a HTLV es baja (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;27(3): 165-167, mar. 2009. tab</dc:source>
<dc:identifier>ibc-61352</dc:identifier>
<dc:title xml:lang="es">Cribado prenatal de la infección por Trypanosoma cruzi y virus linfotrópico humano de células T en gestantes latinoamericanas</dc:title>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d23680^s22080</dc:subject>
<dc:subject>^d11732</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30425^s22062</dc:subject>
<dc:subject>^d24874</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d14752^s22001</dc:subject>
<dc:subject>^d25123</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d8022^s22080</dc:subject>
<dc:subject>^d14752^s22052</dc:subject>
<dc:subject>^d11691^s22080</dc:subject>
<dc:subject>^d30425^s22080</dc:subject>
<dc:subject>^d11691^s22062</dc:subject>
<dc:subject>^d23676^s22052</dc:subject>
<dc:subject>^d23676^s22001</dc:subject>
<dc:subject>^d23680^s22062</dc:subject>
<dc:type>article</dc:type>
<dc:date>200903</dc:date>
</metadata>
</record>
</ibecs-document>
